GT
SRRA

Greenleaf Trust’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Greenleaf Trust’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-5,404
Closed -$74K – 618
2019
Q4 		$74K Hold
5,404
– – ﹤0.01% 545
2019
Q3 		$84K Hold
5,404
– – ﹤0.01% 550
2019
Q2 		$121K Hold
5,404
– – ﹤0.01% 532
2019
Q1 		$370K Hold
5,404
– – 0.01% 336
2018
Q4 		$285K Hold
5,404
– – 0.01% 375
2018
Q3 		$368K Hold
5,404
– – 0.01% 340
2018
Q2 		$640K Hold
5,404
– – 0.01% 224
2018
Q1 		$447K Buy
5,404
+206
+4% +$23.4K 0.01% 257
2017
Q4 		$776K Sell
5,198
-93
-2% -$8.94K 0.02% 183
2017
Q3 		$328K Sell
5,291
-250
-5% -$14.7K 0.01% 293
2017
Q2 		$259K Buy
5,541
+188
+4% +$9.6K 0.01% 301
2017
Q1 		$328K Hold
5,353
– – 0.01% 210
2016
Q4 		$319K Buy
5,353
+508
+10% +$31.7K 0.01% 172
2016
Q3 		$353K Sell
4,845
-341
-7% -$26.4K 0.01% 142
2016
Q2 		$413K Buy
5,186
+374
+8% +$71.3K 0.01% 119
2016
Q1 		$1.3M Buy
4,812
+42
+0.9% +$13.4K 0.04% 79
2015
Q4 		$2.87M Buy
4,770
+2,345
+97% +$1.59M 0.09% 53
2015
Q3 		$1.99M Buy
+2,425
New +$2.73M 0.06% 44

Other funds holding SRRA

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Greenleaf Trust's SRRA Position: Q1 2020 in Review

Greenleaf Trust sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q1 2020, closing a stake of 5,404 shares — an estimated $74K sold.

Greenleaf Trust first reported a position in SRRA in Q3 2015 and held it in 18 quarters. The position peaked at $2.87M in Q4 2015. 22 funds tracked by Wall St. Rank hold SRRA as of Q1 2020.

  • Greenleaf Trust reported no remaining Sierra Oncology, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • Greenleaf Trust sold 5,404 Sierra Oncology, Inc. Common Stock shares in Q1 2020, an estimated $74K.
  • Greenleaf Trust first reported a position in Sierra Oncology, Inc. Common Stock in Q3 2015 and held it in 18 quarters.
  • Greenleaf Trust's Sierra Oncology, Inc. Common Stock position peaked at $2.87M in Q4 2015.
  • 22 funds tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q1 2020.

Based on Greenleaf Trust's 13F filing for Q1 2020, filed 29 Apr 2020.